Novartis beats expectations for third quarter
Core earnings per share ended the period at a higher level than analysts' estimates for Novartis's Q3.
BY MARKETWIRE, TRANSLATED BY DANIEL PEDERSEN
Novartis finishes the third quarter of the year better than analysts had anticipated, including outperforming in core earnings per share (EPS), reports Bloomberg News.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
